GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative: London, UK Thursday, March 27, 2025, 09:00 Hrs [I ...

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

GSK said it plans to launch the new product in ... immunocompromised, or have a medical condition that could lead to patients requiring more extensive treatment for the infection.

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...

GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...